Craneware (LON:CRW) Receives Buy Rating from Shore Capital

Shore Capital reissued their buy rating on shares of Craneware (LON:CRW) in a research report released on Tuesday morning, Marketbeat reports.

Separately, Berenberg Bank restated a “buy” rating and set a GBX 2,700 ($34.50) price objective on shares of Craneware in a research report on Tuesday, September 3rd.

Craneware Price Performance

CRW stock opened at GBX 2,350 ($30.02) on Tuesday. The business has a 50 day moving average price of GBX 2,096.61 and a 200 day moving average price of GBX 2,233.48. The company has a quick ratio of 1.00, a current ratio of 0.63 and a debt-to-equity ratio of 12.22. The stock has a market cap of £830.49 million, a price-to-earnings ratio of 9,038.46 and a beta of 0.28. Craneware has a fifty-two week low of GBX 1,620 ($20.70) and a fifty-two week high of GBX 2,509.20 ($32.06).

About Craneware

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors.